Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Latest filing published 01 Sept 2026 for CYTOKINETICS INC, €308k. Read the official filing
Filing timeline
BuySaleB. Lynne Parshall
Insider track record
Disclosed buys
0
Disclosed sells
16
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
B. Lynne Parshall: trading record in brief
Filings by B. Lynne Parshall span 2 companies, the busiest being Ionis Pharmaceuticals Inc and Cytokinetics Inc. In total, 46 filings cover trades dated from 1 January 2016 to 1 September 2026.
Every open-market trade on record is a sale: 16 sales worth €3.2M. The totals exclude 5 filings filed without an amount. Outside the open market, there are 6 share grants and 23 option exercises. So far in 2026, the count stands at no purchases and 6 sales.
The latest filing, published on 1 September 2026, reports an open-market sale of €308k in Cytokinetics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to B. Lynne Parshall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
5,000 shares@ US$71.480.0036% mcap14.9% of flowCommon StockSEC:0001061983-26-000091:0
5,000 shares@ US$74.080.0041% mcap21.6% of flowCommon StockSEC:0001061983-26-000064:0
2,851 shares0Common StockSEC:0001061983-26-000057:0
4,466 shares@ US$76.190.0034% mcap15.8% of flowCommon StockSEC:0000874015-26-000172:0
534 shares@ US$76.970.0004% mcap1.9% of flowCommon StockSEC:0000874015-26-000172:1
5,000 shares@ US$61.2114.8% of flowCommon StockSEC:0001061983-26-000014:0
5,000 shares@ US$82.717711.2% of flowCommon StockSEC:0000874015-26-000110:0
5,000 shares@ US$64.7318.7% of flowCommon StockSEC:0001061983-25-000038:0
5,000 shares@ US$71.744311.1% of flowCommon StockSEC:0000874015-25-000261:0
10,750 shares@ US$50.4218.9% of flowCommon StockSEC:0000874015-25-000222:0
4,600 shares@ US$41.86858.3% of flowCommon StockSEC:0000874015-25-000176:0
4,079 shares0Common StockSEC:0000874015-25-000159:0
7,333 shares0Common StockSEC:0001127602-25-014552:0
5,000 shares@ US$21.616.6% of flowCommon StockSEC:0001127602-24-023646:0
5,000 shares@ US$21.616.6% of flowCommon StockSEC:0001127602-24-022909:0
5,000 shares@ US$21.616.7% of flowCommon StockSEC:0001127602-24-022026:0
5,000 shares@ US$21.616.8% of flowCommon StockSEC:0001127602-24-021231:0
4,677 shares0Common StockSEC:0000874015-24-000182:0
5,000 shares@ US$10.683.3% of flowCommon StockSEC:0001127602-24-020524:0
5,000 shares@ US$10.683.4% of flowCommon StockSEC:0001127602-24-019621:0
5,000 shares@ US$10.683.4% of flowCommon StockSEC:0001127602-24-018859:0
5,000 shares@ US$10.683.3% of flowCommon StockSEC:0001127602-24-017694:0
5,600 shares0Common StockSEC:0001127602-24-015720:0
25,113 shares@ US$47.3471.6% of flowCommon StockSEC:0000874015-23-000241:0
10,000 shares@ US$45.1268100.0% of flowCommon StockSEC:0000874015-23-000197:0
25 of 46 declarations
